Ameriflex Group Inc. Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Ameriflex Group Inc. acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, HoldingsChannel reports. The fund acquired 757 shares of the healthcare conglomerate’s stock, valued at approximately $411,000.

A number of other large investors also recently bought and sold shares of UNH. Norges Bank purchased a new position in UnitedHealth Group in the 4th quarter valued at approximately $6,375,744,000. Raymond James Financial Inc. purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at $1,914,740,000. Amundi boosted its position in shares of UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock worth $3,183,132,000 after buying an additional 2,991,470 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in UnitedHealth Group by 36.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock valued at $4,346,712,000 after acquiring an additional 2,301,010 shares in the last quarter. Finally, Proficio Capital Partners LLC lifted its holdings in shares of UnitedHealth Group by 76,830.4% in the fourth quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate’s stock valued at $955,388,000 after purchasing an additional 1,886,186 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have commented on UNH. Wells Fargo & Company lowered their target price on UnitedHealth Group from $677.00 to $351.00 and set an “overweight” rating on the stock in a report on Wednesday, May 14th. Barclays dropped their price objective on UnitedHealth Group from $513.00 to $362.00 and set an “overweight” rating for the company in a research report on Thursday, May 15th. Hsbc Global Res cut shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, May 21st. Raymond James downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research note on Wednesday, May 14th. Finally, Bank of America cut shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $560.00 to $350.00 in a research note on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $441.87.

UnitedHealth Group Trading Down 0.4%

UnitedHealth Group stock opened at $295.37 on Monday. The firm has a 50-day moving average price of $452.40 and a two-hundred day moving average price of $503.72. The firm has a market capitalization of $267.94 billion, a price-to-earnings ratio of 19.06, a PEG ratio of 1.37 and a beta of 0.56. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the previous year, the business posted $6.91 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insiders Place Their Bets

In other UnitedHealth Group news, CFO John F. Rex acquired 17,175 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the purchase, the chief financial officer now owns 203,796 shares in the company, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Kristen Gil acquired 3,700 shares of the company’s stock in a transaction on Thursday, May 15th. The stock was bought at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the purchase, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 109,408 shares of company stock worth $31,607,768. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.